Table 4.
Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Sex (male) | 0.956 | 0.870–1.051 | 0.354 | |||
Gestational age (weeks) | 1.073 | 1.029–1.120 | < 0.001 | 1.077 | 1.033–1.122 | < 0.001 |
Birth weight (g) | 1.000 | 1.000–1.000 | 0.033 | 1.000 | 1.000–1.000 | 0.766 |
Weight at admission (Kg) | 1.147 | 1.093–1.203 | < 0.001 | 1.003 | 0.904–1.112 | 0.960 |
Age (months) | 1.057 | 1.032–1.083 | < 0.001 | 1.062 | 1.035–1.091 | < 0.001 |
Underlying disease | 0.685 | 0.484–0.971 | 0.033 | 0.578 | 0.400–0.836 | 0.004 |
Prematurity | 0.750 | 0.577–0,974 | 0.031 | 1.049 | 0.705–1.562 | 0.812 |
Caesarean section | 0.951 | 0.779–1.161 | 0.620 | |||
Personal history atopy | 0.916 | 0.637–1.319 | 0.638 | |||
Apnea | 0.417 | 0.275–0.632 | < 0.001 | 0.725 | 0.465–1.130 | 0.155 |
Sepsis | 0.275 | 0.129–0.585 | < 0.001 | 0.253 | 0.117–0.548 | < 0.001 |
Breastfeeding | 0.910 | 0.748–1.106 | 0.341 | |||
*Ventilatory support | 0.347 | 0.283–0.425 | < 0.001 | 0.332 | 0.267–0.413 | < 0.001 |
PICU admission | 0.413 | 0.329–0.518 | < 0.001 | 0.863 | 0.623–1.196 | 0.376 |
RSV | 0.883 | 0.707–1.104 | 0.275 | 0.979 | 0.747–1.283 | 0.877 |
Rhinovirus/enterovirus | 1.038 | 0.853–1.262 | 0.713 | |||
Coronavirus | 0.679 | 0.486–0.949 | 0.023 | 0.770 | 0.523–1.134 | 0.185 |
Bocavirus | 0.802 | 0.574–1.120 | 0.195 | 0.956 | 0.627–1.457 | 0.833 |
Parainfluenza | 0.812 | 0.568–1.161 | 0.254 | |||
Human Metapneumovirus | 0.766 | 0.511–1.148 | 0.197 | 0.740 | 0.486–1.126 | 0.159 |
Adenovirus | 1.293 | 0.815–2.049 | 0.275 | |||
Infuenza | 0.774 | 0.481–1.243 | 0.289 | |||
Viral coinfection | 0.769 | 0.635–0.932 | 0.007 | |||
†Viral co-detections | ||||||
None | 0.011 | 0.002 | ||||
2 Virures ≥ 3 Viruses |
0.831 0.644 |
0.672–1.029 0.474–0.875 |
0.090 0.005 |
0.858 0.568 |
0.688–1.071 0.410–0.785 |
0.176 < 0.001 |
h and 95% CIs are from Cox regression. Bold indicates statistical significance (p < 0.05)
RSV Respiratory syncytial virus
* Ventilatory support includes: HFNC oxygen therapy, NIV and IMV.
† Viral co-detection: Reference group = none